Average Co-Inventor Count = 8.31
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (32 from 329 patents)
2. Eli Lilly and Company (6 from 4,442 patents)
3. Celgene Corporation (2 from 549 patents)
4. Intermune, Inc. (2 from 52 patents)
5. Zoetis LLC (2 from 26 patents)
6. Takeda Pharmaceutical Company Limited (1 from 1,177 patents)
42 patents:
1. 12338235 - Heterocyclic compounds and their use for treatment of helminthic infections and diseases
2. 12209086 - FGFR3 inhibitor compounds
3. 11970485 - RET kinase inhibitors
4. 11964968 - Compounds useful for inhibiting RET kinase
5. 11878976 - FGFR3 inhibitor compounds
6. 11697647 - RET kinase inhibitors
7. 11613533 - Compounds useful for inhibiting RET kinase
8. 11505548 - Heterocyclic compounds and their use for treatment of helminthic infections and diseases
9. 10758542 - Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors
10. 10647730 - Macrocyclic compounds as TRK kinase inhibitors
11. 10323022 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
12. 10251889 - Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
13. 9902741 - Macrocyclic compounds as TRK kinase inhibitors
14. 9878997 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
15. 9840519 - Macrocyclic compounds as TRK kinase inhibitors